Sinopia Biosciences

About:

Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

Website: http://www.sinopiabio.com

Top Investors: Michael J. Fox Foundation, National Institute of Neurological Disorders and Stroke, National Heart, Lung and Blood Institute, National Institute of General Medical Science, National Institute of Dental and Craniofacial Research (NIDCR)

Description:

Sinopia Biosciences is transforming drug discovery and illness research. For the past thirty years, target-based drug discovery has been the predominant method. However, phenotypic screening has shown greater productivity in the discovery of first-in-class medications due to the fact that the pathogenesis of many diseases is often complex and the etiology of many diseases is unclear.